Real-time enrollment status for this nsclc clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 9:04 AM UTC
| NCT Number | NCT04077099 |
| Recruiting Status | Recruiting |
| Condition | NSCLC |
| Phase | PHASE1 |
| Target Enrollment | 231 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | June 17, 2026 (Jun 17, 2026) |
As of August 28, 2026: Clinical trial NCT04077099 is currently recruiting participants. This phase1 study for nsclc is actively seeking new participants at 18 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04077099 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04077099 was last updated Jun 17, 2026 (June 17, 2026). HelloStudys verifies this status automatically.